HPGC Renmintongtai Pharmaceutical Corporation Share Price
Stocks
600829
CNE000000G05
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 8.420 CNY | -1.64% |
|
-2.21% | -22.11% |
| Market Cap | 4.88B 734M 657M 604M 548M 1.02B 69.66B 1.04B 7.21B 2.89B 36.64B 2.75B 2.69B 116B | P/E 2024 |
20.4x | P/E 2025 | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.38B 658M 589M 542M 491M 918M 62.48B 935M 6.46B 2.6B 32.87B 2.47B 2.42B 104B | EV / Sales 2024 |
0.41x | EV / Sales 2025 | 0.56x |
| Free-Float |
24.63% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.64% | ||
| 1 week | -2.21% | ||
| Current month | -10.71% | ||
| 1 month | -9.75% | ||
| 3 months | -6.96% | ||
| 6 months | -13.02% | ||
| Current year | -22.11% |
| 1 week | 8.33 |  | 9.57 |
| 1 month | 8.21 | | 9.66 |
| Current year | 7.54 | | 13.16 |
| 1 year | 7.54 | | 18.13 |
| 3 years | 4.96 | | 18.13 |
| 5 years | 4.96 | | 18.13 |
| 10 years | 4.88 | | 18.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 57 | 25/09/2016 |
Ping Guan
DFI | Director of Finance/CFO | 54 | 06/04/2022 |
Rui Qu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CHM | Chairman | 57 | 14/12/2023 |
Shi Wei Yin
BRD | Director/Board Member | 51 | 25/12/2023 |
Dan Guo
BRD | Director/Board Member | 56 | 25/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.64% | -2.21% | -0.12% | +12.27% | 745M | |
| +3.11% | +10.92% | +67.26% | +149.68% | 1,224B | |
| -0.50% | +3.81% | +44.87% | +86.27% | 662B | |
| +1.45% | +2.84% | +28.73% | +107.04% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.34% | +3.02% | +73.45% | +45.74% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.45% | +6.28% | +59.88% | +77.38% | 249B | |
| +3.71% | +9.84% | +44.71% | +120.39% | 205B | |
| Average | +1.88% | +1.71% | +41.95% | +76.06% | 417.76B | |
| Weighted average by Cap. | +2.09% | +3.04% | +50.78% | +98.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.05B 1.51B 1.35B 1.24B 1.13B 2.11B 143B 2.15B 14.83B 5.95B 75.4B 5.67B 5.55B 238B | 10.38B 1.56B 1.4B 1.28B 1.16B 2.18B 148B 2.22B 15.32B 6.15B 77.88B 5.85B 5.73B 246B |
| Net income | 213M 32.04M 28.7M 26.4M 23.92M 44.71M 3.04B 45.55M 315M 126M 1.6B 120M 118M 5.05B | 134M 20.11M 18.01M 16.57M 15.01M 28.06M 1.91B 28.58M 198M 79.3M 1B 75.47M 73.86M 3.17B |
| Net Debt | -200M -30M -26.87M -24.72M -22.39M -41.86M -2.85B -42.64M -295M -118M -1.5B -113M -110M -4.73B | -503M -75.58M -67.69M -62.26M -56.41M -105M -7.18B -107M -742M -298M -3.77B -284M -278M -11.9B |
Employees
2,735
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CN¥8.420 | -1.64% | 11,362,400 |
| 29/10/26 | CN¥8.560 | -0.47% | 7,810,600 |
| 28/10/26 | CN¥8.600 | -0.12% | 8,178,737 |
| 27/10/26 | CN¥8.610 | -4.12% | 17,800,739 |
| 26/10/26 | CN¥8.980 | +3.10% | 24,767,300 |
- Stock Market
- Stocks
- 600829 Stock
Select your edition
All financial news and data tailored to specific country editions
